Abortion Industry Pushing Dangerous Abortion Pills

In its 2018 report, the FDA documents “24 deaths of women associated with Mifeprex since the product was approved in September 2000….” as well as noting thousands of cases of additional adverse effects, including many instances of severe bleeding requiring hospitalization and blood transfusions. However, abortion advocates are now pushing to remove FDA safeguards that require women to obtain medication abortions at qualifying facilities from approved prescribers of the pills.

The abortion industry will do anything to make abortion more accessible - even if it means putting women in harm's way.

Watch the rest of our "ShareThis" series here: https://bit.ly/2MKqQMN